The French Paradox — the observation that French populations have relatively low cardiovascular disease mortality despite high saturated fat intake — was proposed in 1991 to be partially explained by red wine consumption and specifically resveratrol. This hypothesis launched two decades of resveratrol research. The mechanism was compelling: resveratrol activates SIRT1, a key longevity regulator also activated by caloric restriction, and produces broad protective effects in cellular and animal models. However, the translation to humans has been repeatedly complicated by the bioavailability problem — resveratrol is rapidly metabolized, the doses required to achieve cellular concentrations that activate SIRT1 are far above what supplements typically deliver, and the clinical trial results have been mixed.
This does not mean polyphenols are without value in human health. The epidemiological data linking high dietary polyphenol intake to reduced disease risk is substantial. The question is mechanism: are polyphenols extending health via SIRT1 and longevity pathways, or primarily via antioxidant, anti-inflammatory, and gut microbiome-modulating effects? For practical purposes, this mechanistic question matters less than the evidence for specific outcomes — and the evidence for specific polyphenols in specific applications is the most actionable frame.
| Polyphenol | Primary Mechanism | Best Human Evidence | Bioavailability | Dose | Evidence Tier |
|---|---|---|---|---|---|
| Quercetin | Senolytic (clears senescent cells); anti-inflammatory (NF-κB inhibition); zinc ionophore | Kirkland 2019 pilot (N=14): quercetin + dasatinib reduced senescent cell burden; anti-inflammatory in OA and allergies | Poor alone; improved with bromelain or phospholipid complex | 500–1000mg with bromelain | Strong senolytic pilot; good anti-inflammatory; longevity mechanistic evidence promising but limited RCTs |
| Fisetin | Potent senolytic; SIRT1 activator; anti-inflammatory | Yousefzadeh 2018 (EBioMedicine): fisetin most potent senolytic of 10 polyphenols tested in mice; extended median lifespan 10%; pilot human data (Mayo Clinic) in older adults pending publication | Low; fat-soluble; take with food | 100–500mg with fatty meal; pulse dosing (2–3 days/month senolytic protocol) | Best animal senolytic data; limited human RCTs; among the most promising polyphenols for longevity |
| EGCG (green tea) | AMPK activation; autophagy induction; anti-inflammatory; catechol methyltransferase inhibition → increased norepinephrine | Numerous RCTs in metabolic health; modest weight loss, cholesterol reduction; anti-cancer in prospective studies (Japanese green tea consumption data) | Moderate; better absorbed fasted; standardized extract (50% EGCG) more reliable than brewed tea | 300–600mg EGCG; cycle off monthly (liver caution at high doses continuous) | Strong anti-inflammatory and metabolic evidence; longevity pathway activation well-supported mechanistically; hepatotoxicity risk at >800mg/day requires caution |
| Pterostilbene | SIRT1 activation; anti-inflammatory; PPAR-α agonism (fat oxidation); blood glucose reduction | MacRae 2013 (J Agric Food Chem): 50mg/day reduced LDL and blood pressure in adults; limited longevity RCTs but mechanistically superior to resveratrol | High vs resveratrol; 4× better bioavailability | 50–100mg/day | Mechanistically strong; better bioavailability than resveratrol; limited large human RCTs; preferred over resveratrol by many researchers |
| Resveratrol | SIRT1 activation (debated); NF-κB inhibition; AMPK activation; autophagy induction | Timmers 2011 (Cell Metabolism, N=11): 150mg/day in obese men: improved insulin sensitivity, mitochondrial function, reduced BP; BUT Poulsen 2013 (J Physiol, N=27): resveratrol blocked exercise adaptation improvements; mixed results in cancer and cardiovascular human trials | Very low (1%) without fat; micronized or liposomal formulations substantially better | 500mg–1g/day with fat; use micronized form | Strong mechanistic story; mixed human RCT evidence; bioavailability is the central limitation; pterostilbene is likely superior |
| Curcumin | NF-κB inhibitor; COX-2 inhibitor; AMPK activation; Nrf2 activation | Meta-analysis 2021 (Phytotherapy Research, 32 RCTs): curcumin significantly reduced CRP, IL-6, TNF-α; OA pain comparable to NSAIDs in some trials; depression adjunct therapy signal | Very low alone (<1%); piperine 20mg increases 2,000%; liposomal (Meriva) or BCM-95 formulations achieve 6–8× standard powder | 500–2000mg + 20mg piperine or use liposomal form | Strongest anti-inflammatory polyphenol evidence in humans; longevity pathway activation plausible; requires enhanced formulation for any meaningful absorption |
General longevity / anti-aging foundation: Fisetin 500mg with fatty meal 2–3 consecutive days per month (senolytic pulse dosing, Mayo Clinic protocol framework); pterostilbene 50mg daily (SIRT1 activation, better bioavailability than resveratrol); EGCG 400mg in the morning (AMPK activation, autophagy support); quercetin 500mg with bromelain daily (anti-inflammatory, additional senolytic activity on non-fisetin days).
Anti-inflammatory focus: Curcumin 1000mg + piperine 20mg with largest meal (NF-κB, COX-2 inhibition); EGCG 300–600mg fasted or with minimal food; quercetin 500mg; omega-3 EPA+DHA 2–4g (synergistic anti-inflammatory via eicosanoid modulation). This stack addresses multiple inflammatory pathways simultaneously.
Food-first polyphenol strategy (pragmatic alternative): The diet highest in polyphenols by ORAC score: blueberries, blackberries, pomegranate, dark chocolate (>70% cacao), green tea, extra virgin olive oil, red wine (moderate), turmeric, cloves, and dried herbs. 30+ plant foods/week provides diverse polyphenol exposure across flavonoids, stilbenes, phenolic acids, and lignans. Supplementation is additive to food sources, not a substitute for dietary polyphenol diversity.
Cautions: EGCG >800mg/day continuous use has been associated with liver enzyme elevation in case reports — cycle off 1 week per month; quercetin may interfere with thyroid hormone absorption (take 2+ hours apart from thyroid medication); curcumin may increase bleeding risk at high doses; resveratrol may antagonize exercise adaptation at high doses (Poulsen 2013) — take on rest days if this is a concern.
As an Amazon Associate, LongevityLab earns from qualifying purchases made through links on this page. This does not affect the price you pay.